This comprehensive screening is designed to assess key markers associated with multiple myeloma, plasma cell disorders, and monoclonal gammopathy. It evaluates immune system activity, inflammation, blood proteins, and kidney function to provide a clear picture of your internal health.
Measures the rate at which red blood cells settle in a test tube — a general indicator of inflammation in the body. Often raised in chronic conditions like myeloma.
Evaluates kidney function, calcium, albumin, total protein, and other essential blood chemistry markers that are commonly affected by plasma cell disorders.
Separates blood proteins to detect abnormal monoclonal (M) proteins, which are often present in myeloma and related diseases.
Measures levels of your body’s major antibodies. Abnormalities may signal an overproduction or deficiency of specific immunoglobulin types — often seen in blood cancers.
Highly sensitive for detecting light chain myeloma. This test measures free immunoglobulin light chains that may not show on standard protein electrophoresis.
Please fast for 8 to 12 hours before your appointment.
This test is recommended for those with symptoms such as:
Results are typically available within 5–10 working days via your secure online health dashboard. You’ll receive an email once your personalised report is ready.
Your report will highlight any abnormal results and explain what they may mean. If further investigation is needed, you will be advised to follow up with your GP or a specialist (e.g. haematologist).
This screening helps detect the presence of markers associated with myeloma, but a confirmed diagnosis requires further tests such as imaging or bone marrow biopsy. If concerning signs are found, we’ll guide you on the next steps.
